401 results on '"Low, Audrey"'
Search Results
2. The role of cerebral small vessel disease in dementia
3. LipidSIM: Inferring mechanistic lipid biosynthesis perturbations from lipidomics with a flexible, low-parameter, Markov modeling framework
4. Associations Between Retinal Microvasculature Changes and Gray Matter Volume in a Mid-Life Cohort at Risk of Developing Alzheimer’s Disease
5. Socially Challenged Collaborative Learning of Secondary School Students in Singapore
6. Associations Between Retinal Microvasculature Changes and Gray Matter Volume in a Mid-Life Cohort at Risk of Developing Alzheimer’s Disease
7. Differential association of cerebral blood flow and anisocytosis in APOE ε4 carriers at midlife
8. Macrostructural brain alterations at midlife are connected to cardiovascular and not inherited risk of future dementia: the PREVENT-Dementia study
9. Environmental and societal factors associated with COVID-19-related death in people with rheumatic disease: an observational study
10. Modifiable and non-modifiable risk factors of dementia on midlife cerebral small vessel disease in cognitively healthy middle-aged adults: the PREVENT-Dementia study
11. Outcomes of COVID-19 in patients with primary systemic vasculitis or polymyalgia rheumatica from the COVID-19 Global Rheumatology Alliance physician registry: a retrospective cohort study
12. The Mediterranean diet is not associated with neuroimaging or cognition in middle‐aged adults: a cross‐sectional analysis of the PREVENT dementia programme
13. In vivo coupling of dendritic complexity with presynaptic density in primary tauopathies
14. Proximity to dementia onset and multi-modal neuroimaging changes: The prevent-dementia study
15. Inherited risk of dementia and the progression of cerebral small vessel disease and inflammatory markers in cognitively healthy midlife adults: the PREVENT-Dementia study
16. Cerebral Small Vessel Disease Influences Hippocampal Subfield Atrophy in Mild Cognitive Impairment
17. Association of optic disc pallor and RNFL thickness with cerebral small vessel disease in the PREVENT‐Dementia study.
18. Immune regulation and blood–brain barrier permeability in cerebral small vessel disease: study protocol of the INflammation and Small Vessel Disease (INSVD) study – a multicentre prospective cohort study
19. Investigating the impact of APOE4 genotype on the association between cerebral blood flow and haematological properties in mid‐life adults
20. Apoe ε4 exacerbates age‐dependent decline of cortical microstructural changes in cognitively normal midlife individuals: the PREVENT‐Dementia and ALFA studies
21. Dietary patterns, cardiometabolic and brain health in the PREVENT Dementia Cohort
22. DNA methylation alterations in Lewy Body Dementia
23. Cerebral microbleeds in traumatic brain injury associated with differential risk factors and clinical outcomes: the PREVENT‐Dementia study
24. What influence does self‐reported history of single or repeated mild TBI have on cognitive performance and brain volume at mid‐life?
25. Asymmetrical atrophy of thalamic subnuclei in Alzheimer's disease and amyloid-positive mild cognitive impairment is associated with key clinical features
26. The PREVENT dementia programme: baseline demographic, lifestyle, imaging and cognitive data from a midlife cohort study investigating risk factors for dementia.
27. Comprehensive allostatic load risk index is associated with increased frontal and left parietal white matter hyperintensities in mid-life cognitively healthy adults
28. Chemical modification of PS-ASO therapeutics reduces cellular protein-binding and improves the therapeutic index
29. LipidSIM: inferring mechanistic lipid biosynthesis perturbations from lipidomics with a flexible, low-parameter, systematic Markov Modeling framework
30. The PREVENT Dementia programme: Baseline demographic, lifestyle, imaging and cognitive data from a midlife cohort study investigating risk factors for dementia
31. Mutation in the Glycosylated Gag Protein of Murine Leukemia Virus Results in Reduced In Vivo Infectivity and a Novel Defect in Viral Budding or Release▿
32. APOE ɛ4 exacerbates age-dependent deficits in cortical microstructure.
33. CAIDE DEMENTIA RISK SCORE RELATES TO SEVERITY AND PROGRESSION OF CEREBRAL SMALL VESSEL DISEASE IN HEALTHY MIDLIFE ADULTS: THE PREVENT-DEMENTIA
34. Artificial intelligence for diagnostic and prognostic neuroimaging in dementia: A systematic review.
35. Hydroxychloroquine baseline retinopathy screening: when to refer patients? A practical approach to optimise resource use
36. Rate of, and risk factors for, white matter hyperintensity growth: a systematic review and meta-analysis with implications for clinical trial design
37. sj-pdf-1-jcb-10.1177_0271678X231173587 - Supplemental material for Differential association of cerebral blood flow and anisocytosis in APOE ε4 carriers at midlife
38. Environmental and societal factors associated with COVID-19-related death in people with rheumatic disease: an observational study
39. Risk of lymphoma in patients exposed to antitumour necrosis factor therapy: results from the British Society for Rheumatology Biologics Register for Rheumatoid Arthritis
40. Response to: ‘Does the risk of lymphoma in patients with RA treated with TNF inhibitors differ according to the histological subtype and the type of TNF inhibitor?’ by Nocturne et al
41. P011 Audit and Outcomes of Hydroxychloroquine Screening for Retinopathy in a Cohort of Patients with Rheumatological Conditions
42. Additional file 1 of Modifiable and non-modifiable risk factors of dementia on midlife cerebral small vessel disease in cognitively healthy middle-aged adults: the PREVENT-Dementia study
43. CAIDE dementia risk score relates to severity and progression of cerebral small vessel disease in healthy midlife adults: the PREVENT-Dementia study
44. Evaluation of Phosphorus and Non-Phosphorus Neutral Oligonucleotide Backbones for Enhancing Therapeutic Index of Gapmer Antisense Oligonucleotides
45. Tmprss6-ASO as a tool for the treatment of Polycythemia Vera mice
46. The effects of age and hypertension on cerebral small‐vessel disease differ between men and women at midlife: The PREVENT Dementia study
47. Outcomes of COVID-19 in patients with primary systemic vasculitis or polymyalgia rheumatica from the COVID-19 Global Rheumatology Alliance physician registry: a retrospective cohort study
48. Association Between Ischemic Stroke and Tumor Necrosis Factor Inhibitor Therapy in Patients With Rheumatoid Arthritis
49. Risk of solid cancer in patients exposed to anti-tumour necrosis factor therapy: results from the British Society for Rheumatology Biologics Register for Rheumatoid Arthritis
50. Towards next generation antisense oligonucleotides: mesylphosphoramidate modification improves therapeutic index and duration of effect of gapmer antisense oligonucleotides
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.